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issue excites as much angst among 
members of the medical staff than that 
of the medical manpower plan. A 
detailed discussion of this issue took 
place at the .Medical 
Staff/ Administrative Exchange 
Session on Thursday, June 15, 1995. 
Here are some of the highlights. 
The medical manpower plan was 
developed initially in 1982 to identify 
those specialties and sub-specialties 
faced with inadequate supply of 
physicians, or in which a supply of 
physicians was likely to exceed the 
resources available within the hospital. 
Input was solicited from 36 
Division/Section meetings. The result 
was an adjustment driven plan in 1982 
which had many problems. By 
September of 1986, the plan was 
developed to include a semi-annual 
needs survey where physicians could 
II • ll II ub 't th • sem1-annua y s m1 etr requests 
for additional manpower through a 
formal process. Specification 
statements, including the two-year 
rule, capitations, stipulations and 
compatibility statements, were made at 
that time. "Brainstorming" groups 
which incl~ded all the Chairpersons, 
. 
the CEO, Medical Staff President, the 
Senior Vice President for Medical and 
Academic Affairs, the Senior Vice 
President of Lehigh Valley Health 
Services Division, and the Vice 
President for Medical Staff Services 
met to review and discuss these needs 
which were then debated by the 
Medical Executive Committee who 
remained involved in the review and 
approval process. The Board of 
Trustees had the final action in all 
requests at that time as it does now. 
In 1993, the Med Exec created a 
separate body to consider manpower 
needs and removed itself from the 
process of slot approvals, denials and 
revisions. This was done after a 
prolonged and thorough discussion by 
members of the Medical Executive 
Committee who concluded they had an 
ethical obligation to refer this material 
to a separate board due to increasing 
conflict of interest which tainted them 
from making unbiased decisions. A 
new process of assessing staff 
development was created by instituting 
a formal poll of the medical staff which 
requests their objective assessment of 
manpower needs. In this survey, every 
member of every division has the 
opportunity to comment on whether 
(Continued on Page 2) 
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they feel that their neighboring 
divisions and departments are meeting 
their needs in the care of patients. 
This single summary source of the 
medical staff proves to be the most 
objective and important document in 
the assessment of manpower needs. 
Currently, members of the medical 
staff may submit their request for 
increased manpower semi-annually 
during the time periods from August 
15 through September 14, and again 
from February 15 through March 14. 
Department Chairpersons solicit input 
and formal recommendation from the 
Division/Section Chiefs and carry 
those recommendations to the 
monthly meeting of the TROIKA/ 
Chairpersons Committee, which 
consists of 12 department 
Chairpersons, the CEO, the COO, 
the Senior Vice President of Clinical 
Services, the Vice President for 
Medical Staff Services, the Medical 
Staff President, Past President of the 
Medical Staff, and the Medical Staff 
President-Elect. Recommendations 
from the Combined TROIKA/ 
Chairpersons Committee are presented 
to the Performance Improvement/ 
Staff Development Committee of the 
Board of Trustees, which then submits 
the final recommendation to the 
Board of Trustees. A report from the 
Combined TROIKA/Chairpersons 
Committee is given to Med Exec for 
information purposes only. The Board 
of Trustees ultimately makes the final 
decision on the request for that 
additional medical manpower based on 
recommendations forwarded to them 
by these groups. 
Currently, the Hospital Staff 
Development Plan retains "a two-year 
rule" given to physicians who are ( · 
voluntarily terminated from practice 
prior to a two year date. It reads as 
follows: 
"Immediately upon the receipt of 
notification from a private practice 
group that an individual has been 
involuntarily terminated from his 
group, or when an individual is no 
longer employed under a contract with 
the hospital, the individual would lose 
medical staff privileges and 
membership. These individuals would, 
however, be permitted to request a slot 
within 60 days of such notification 
requiring immediate consideration by 
the TROIKA/Chairpersons 
Committee, the Staff Development 
Committee of the Board of Trustees, 
and the Board of Trustees at their next 
scheduled meeting. Voluntary ( 
termination from either private 
practice group or hospital contracts 
will be reviewed only during the normal 
semi-annual needs survey cycle." 
There remains some common 
misconceptions of the Hospital Staff 
Development Plan which I thought 
would be worth restating here: 
e Slots are automatically granted 
when an individual leaves the group or 
retires. 
This statement is false. Even when a 
senior member of a group retires, that 
slot is not automatically granted to the 
group and needs to be requested and 
moved through the process from 
(Continued on Page 3) 
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Division to Department Chairperson 
to the Board. While it is usually the 
case that replacement slots are granted, 
it is not automatic and in some 
instances planned attrition of divisions 
would require that replacement slots 
not be filled. 
e Division/Section should vote on slot 
requests. 
The plan mandates Division/Section 
Chiefs give a formal recommendation 
and it is encouraged that discussion of 
manpower needs in general take place 
at Division/Section meetings. 
However, votes on individual slot 
requests in these meetings should be 
avoided as they are a violation of 
federal anti-trust laws. This prevents 
small divisions with perhaps a single 
group from unfairly stamping out 
competition by preventing new 
members to join their group, even 
when it is felt it is needed by the 
manpower survey and the 
TROIKNChairpersons Committee to 
meet patient care needs. 
• Division/Section Chief 
recommendations are automatically 
approved by the Chairperson, the 
TROIKNChairperson Committee and 
the Board of Trustees. 
The Division/Section Chiefs 
recommendations are taken very 
seriously and carry a great deal of . 
weight. They are also weighed with the 
individual need of a particular group, 
particularly a group that has provided 
loyal service to this hospital and its 
patients or has been intimately 
involved in the teaching program. 
e Hospital slots are equivalent to 
Lehigh Valley Physician Group 
employed physicians. 
Often Chairpersons will identify 
"hospital slots" and these are mistaken 
as slots for members employed by the 
Lehigh Valley Physician Group. The 
term "hospital slot" simply means it is 
a generic slot which can be filled by 
any member of the division or L VPG, 
and is not given to one specific group. 
For example, if the need for a pediatric 
surgeon was identified as a hospital 
slot, that slot could be filled by any 
member of the private practice groups 
or by L VPG during the search process. 
e Approved slots are good for two 
years. 
Slots are approved for a period of one 
year and an opportunity exists to make 
a request to have the slot renewed for 
an additional second year. This 
approval is by no means automatic and 
all requests for renewal will be 
considered in the same manner as 
original slot requests. An excerpt from 
the plan follows, which deals with the 
Board of Trustee's right to eliminate 
existing slots: 
"While the Board recognizes its 
ultimate right to consider the 
appropriate number of medical 
specialists and sub-specialists to 
provide optimal care to patients the 
hospital serves, it envisions that this 
will be regulated through access to the 
medical staff via the staff development 
plan process rather than retrospective 
elimination of slots. However, because 
(Continued on Page 4) 
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of constant and frequent changes in 
health care delivery system, it may be 
counter productive to the hospital's 
well being to continue certain existing 
vacant unfilled slots. Therefore, the 
Board of Trustees reserves the right to 
eliminate already approved slots." 
e Slots can be requested at any time. 
Slots for a group can only be requested 
during the semi-annual needs survey, 
during the time periods from August 
15 through September 14, and again 
from February 15 through March 14. 
Hence, this requires some planning by 
everyone on the medical staff. 
e Slot requests are necessary for active 
staff only. 
This is not true. Slot apP.rovals are 
required for all active staH and 
currently courtesy staff in the 
Department of Surgery. The Plan has 
been amended from time to time to 
permit inclusion of staff categories 
other than active to be included in the 
approval process of the plan. 
e The dissolution of a group entitles 
the resulting separate entities to new or 
existing open slots. 
This issue is obviously complex and 
one which again is poorly understood. 
It evokes the two-year rule for 
members that leave \'rior to two years 
with a grouJ?, hence losing their slot, 
and those that have been with a group 
over two years to carry their slot with 
them. Other than that, existing open 
slots are not carried away from the 
original group from which they have 
been awarded. 
The July 20, 1995 Medical 
Staff/ Administrative Exchange 
Session was dedicated to the discussic( 
of the Lehigh Valley ~hysician Group 
which employs the full-time physicians 
here at the hospital. The results of 
that discussion will be shared in a 
future issue of Medical Staff Progress 
Notes. 
The re-design of the medica1!surgical 
floors under the concept of "patient 
centered care" is \'rogressing at the 
expected pace with 7A being complete 
and 7B and 7C almost complete at 
this time. The nurses on 6B and 
medical directors of that floor have 
been involved with planning the future 
of that endeavor as well. We 
appreciate many of your helJ?ful 
comments, and anticipate that each 
time we build a new floor we will 
incotporate these suggestions into the 
new Hoar and again improve on it. 
One clear cut improvement which is ( 
necessary is additional writing space 
for physicians. On 7A, 7B and 7C, 
we will move the computers off the 
writing space that is P.rovided for the 
physicians and we will also provide 
foldout writing carousels at each of the 
doors to hold the charts. We 
anticipate that these carousels will have 
the ability to be "flagged" when orders 
on charts are written. Please don't 
hesitate to forward your suggestions to 
me in order to make these areas as 
useful to physicians and nurses as 
possible. 
I hope you all are enjoying the 
beautiful summer weather. 
~~~~ 
John E. Castaldo, M.D. 
President, Medical Staff 
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Director o/ Emergency Services Named 
Elizabeth Brennan, RN, EdD, 
CCRN, has been named Director of 
Emergency Services and MedEvac. 
In her new position, Dr. Brennan will 
be responsible for the Emergency 
Department at both Cedar Crest & 1-
78 and 17th & Chew and the 
MedEvac team. 
Previously, Dr. Brennan was manager 
of the Emergency Department at 
Albert Einstein Medical Center in 
New Telephone 
Numbers /or Patient 
Centered Care Units 
Patient related phone calls should be 
directed to the Patient Team area 
phone extension identified below which 
corresponds to the patient's room 
nwnber: 
7B 
Team Area 1 - Rooms 1-5 - #8761 
Team Area 2- Rooms 6-10- #8792 
Team Area 3- Rooms 11-14- #8793 
Team Area 4- Rooms 15-18- #8794 
The phone extension for calls not 
related to a specific patient is 8795. 
7C 
Team Area 1 -Rooms 1-5- #1981 
Team Area 2- Rooms 7-10- #1982 
Team Area 3- Rooms 11-15-#1983 
Team Area 4- Roomsl6-19- #1974 
The phone extension for calls not 
related to a specific patient is 8755. 
Philadelphia. She has done extensive 
consulting in facility and systems 
redesign related to emergency services. 
Dr. Brennan received her nursing 
degree from Delaware County 
Community College and a doctorate in 
Health Education from Temple 
University. 
REMINDER 
When a patient exPires, it is 
the responsibility of the 
family/significant other to 
contact the funeral director. If 
a patient does not have any 
family/significant other, contact 
the Social Service Department 
for assistance. 
It is extremely important that 
this be communicated during 
your interactions with the 
family/significant other of the 
deceased patient as they may 
otherwise assume that the 
hospital will contact the funeral 
director. 
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L VDI Diagnostic Results Now Available through 
PHAMIS 
Effective ]Wle 28, Lehigh Valley 
Diagnostic Imaging {L VD I) began 
using PHAMIS for their diagnostic 
reporting. You may now access LVDI 
results via Ancillary Transcription 
Review within the MPI command. 
This implementation includes all 
outpatient studies and Cedar Crest 
inpatient mammographies. 
However, as orders may not be placed 
on PHAMIS for LVDI, please 
continue to call L VDI at 435-1600 
for an appointment. LVDI will enter 
the necessary information for you. In 
addition, LVDI will continue to 
perform procedures on a walk-in basis 
as well. 
Admitting Protocol Changes at 17th & Chew 
Effective July 2, responsibility for 
admitting patients was shifted to the 
Emergency Department Registrar 
beginning at 8:30p.m., Monday 
through Friday, noon on Saturday, 
and all day on Sunday. This change 
allows for enhanced service to patients 
during peak volume times. The 
Emergency Department Registrar is 
located on the ground floor at 17th & 
Chew, just off the Emergency 
Department waiting area. 
However, please continue to call402·1 
2217 during these times to contact an 
Admitting registrar regarding 
admissions or any other admitting 
related questions. 
Helwig Diabetes Center Receives State Recognition 
The Helwig Diabetes Center staff 
recently received notification from the 
Pennsylvania Department of Health 
that their outpatient diabetes 
education program meets national 
standards for diabetes patient 
education. 
Recognition is a volm1tary but formal 
process of identifying hospital-based 
diabetes outpatient education 
programs in Pennsylvania that meet 
national standards. Recognition 
provides continuing assurance that an 
education program merits the 
confidence of the commWlity it serves. 
For more information about services 
provided by the Helwig Diabetes 
Center, please contact Kim Sterk, 
Nurse Coordinator, at 402-9885. 
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Guidance Program Opens Bethlehem Office 
Lehigh Valley Hospital's outpatient 
mental health service, the Guidance 
Program, recently opened an office in 
northern Bethlehem to serve persons 
in eastern Lehigh, Northampton, and 
Monroe counties. 
The office is located at 3005 
Brodhead Road, Suite 20, where 
therapists will provide marriage and 
family therapy, conduct art and play 
therapy with children, and treat 
adolescents and adults for depression, 
anxiety, and mood disorders. 
Appointments are available Monday 
through Friday, afternoons and 
evenings. Psychiatric evaluations and 
medication monitoring will continue 
News /rom Research 
Research Advisory Committee 
- Request for Proposals 
The Research Advisory Committee 
(RAC) meets bi-monthly to review 
clinica]f epidemiological research 
proposals (requests for funding) 
submitted by the Medical and 
Professional staff of Lehigh Valley 
Hospital. All proposals must be 
submitted to the Research Department 
for review three weeks before the next 
scheduled RAC meeting. The next 
meeting of the RAC is Thursday, 
August 17. 
For more information or proposal 
guidelines, please contact James F. 
Reed III, PhD, Director of Research, 
at 402-8889. 
to be performed at the Guidance 
Program's main office at 1255 S. 
Cedar Crest Blvd., Suite 3800, 
Allentown. 
The Guidance Program opened in 
1993 to provide short-term mental 
health services to children, adolescents, 
adults, and families. Patients are 
treated for depression, anxiety, marital 
and interpersonal problems, 
psychosomatic disorders, hyperactivity, 
school difficulties, and the effects of 
trauma and abuse. 
For more information or to make an 
appointment, please call the Guidance 
Program at (610) 402-5900. 
Call for Abstracts 
A call for abstracts has been issued by 
the following: 
rr The American College of Cardiology for the 
45th Annual Scientific Session to k held on 
March 24, 1996 in Orlando, Fla. 
Submission due date is Septemkr 8, 1995. 
rr The Institute of Applied Physiology 
Medicine for the 1996 Cerebral 
Hemodynamics Symposium to k held on 
January 22, 1996 in Dallas, Texas. 
Submi81ion due date is Septemkr 8, 1995. 
rr The Society of Critical Care Medicine for 
the 1996 Annual Meeting to k held on 
February 5, 1996. Submission due date is 
Septemher 1, 1995. 
For inst~ctions, forms, and further 
information, contact Kathleen Moser 




George F. Carr, DMD, 
prosthodontist and Vice Chairperson, 
Department of Dentistry, was elected 
President of the Pennsylvania 
Prosthodontic Association at its 
annual meeting held in June in State 
College, Pa. 
Pragnesh A. Desai, DO, urologist, 
was recently notified by the American 
Osteopathic Board of Surgery that he 
successfully completed and passed the 
required examinations for certification 
in Urological Surgery. 
Richard M. Hennan, MD, 
otolaryngologist, recently received 
notification of his certification as a 
Diplomate of the American Board of 
Otolaryngology. 
Ronald A. Kri1ch, MD, psychiatrist, 
was recently elected to Fellowship in 
the American Psychiatric Association. 
Catharine L. Shaner, MD, 
pediatrician, was recently notified by 
the American Board of Pediatrics that 
she has met the requirements for 
renewal of certification in the specialty 
of general pediatrics. 
Papers, Publications and Presentations 
National Emergency Medical Services 
Week was celebrated at Lehigh Valley 
Hospital with a lecture series and light 
dinner for over 150 EMTs and 
paramedics on May 12. Hospital staff 
members who served on the faculty 
included Rohert 0. Atlas, MD, 
Department of Obstetrics and 
Gynecology; and Jerome C. Deutsch, 
DO, and John F. McCarthy, DO, 
Department of Emergency Medicine. 
Alexander M. Rosenau, DO, also 
from the Department of Emergency 
Medicine, was the moderator for the 
evening. 
"Endarterectomy for Asymptomatic 
Carotid Artery Stenosis," a reporl 
detailing the Asymptomatic Carotid 
Atherosclerosis Study in which Lehigh 
Valley Hospital was a participant, was 
published in the May 10, 1995 issue 
of].AMA. John E. Castaldo, MD, 
Medical Staff President, neurologist, 
and a member of the Executive 
Committee for the Asymptomatic 
Carotid Atherosclerosis Study, was one 
of the co-authors of the report. 
Jay S. Cowen, MD, Division of 
Pulmonary Medicine, was one of the 
co-authors of an article, "Recognition, 
Assessment, and Treatment of Anxiety 
in the Critical Care Patient," which 
appeared in the May, 1995 issue of 
Disease-a-Mont/.. In addition, Dr. 
Cowen was among the writing panel 
who developed the Guidelines for 
Resident Training in Critical Care 
Medicine which were approved by the 
governing Council of the Society of 
Critical Care Medicine. 
(Continued on Page 9) 
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Thoma• B. Dickson, MD, 
orthopedic surgeon, attended the 18th 
National Conference and Exhibition 
of the National Strength and 
Conditioning Association from Jnne 
21 to 24. At the conference, held in 
Phoenix, Ariz., Dr. Dickson gave the 
keynote address and a presentation on 
"Drug Use and Testing in Athletics." 
"Preparing For and Managing the 
Podiatric Office Emergency," written 
by Marna R. Greenberg, DO, 
Department of Emergency Medicine, 
was published in the Jnne 1995 edition 
of The Lower Extremity. 
Peter A. Kehlish, MD, chief of the 
Division of Orthopedic Surgery, was 
an invited guest and keynote speaker 
on knee replacement at the Societe 
D'orthopedie-Trawnatologie de l'est de 
la France (SOTES1) in Metz, 
France. Dr. Keblish addressed the 
topic of the basis for total knee 
replacement in surgery of the knee. 
SOTEST is one of two major 
orthopedic societies in France with 
attendance of over 300 orthopedic 
surgeons from the region. Dr. Keblish 
also participated in group discussions 
on various aspects of total joint 
arthroplasty. 
lndru T. Khuhchandani, MD, 
colon-rectal surgeon, was invited to 
give a named oration at the Fifth 
Asian Congress of Coloproctology at 
Seoul, Korea, on Jnne 1 to 4. The 
title of the presentation was 
"Coloproctology -- Has Cinderella 
finally met her Prince Charming?" He 
also spoke about "Complex Fistula in 
Ano" at another session. The meeting 
was attended by 1,299 registrants, 
largely from the East Asian/Pacific 
basin conntries. 
Le1ter Ro1en, MD, Program 
Dii·ector, Colon/Rectal Surgery 
Residency, participated in the 
American College of Surgeons (ACS) 
Advisory Connell meeting in Chicago, 
Ill., on Jnne 7. The ACS Advisory 
Conncil consists of representatives of 
each of the surgical specialties. The 
purpose of the meeting was to gather 
consensus of reporting of surgical 
outcomes. Dr. Rosen was invited to 
this meeting as a consultant to discuss 
how Mediqual software, which is 
legislated for use in Pennsylvania, can 
be used to study outcomes. 
A joint hospital- extended care facility 
- paramedic ronndtable conference was 
held at Lehigh Valley Hospital on May 
9. Alexander M. Rosenau, DO, 
Department of Emergency Medicine, 
lectured and moderated the panel 
discussion as participants identified 
problems and proposed solutions 
concerning the interfacing of these 
three types of caregivers. 
Joseph E. Vincent, MD, chief, 
Division of Pulmonary Medicine, and 
Stephen E. Larnrner1, Ethics 
Consultant, co-authored Chapter 58 --
Ethics and Patient Care of 
Comprehensive Respiratory Care. 
Steven L. Zelenkofske, DO, 
cardiologist, was recently informed 
that his abstract, ''The Effect of Rate 
Modifying Agents on the P-Wave 
Signal Average Electrocardiogram," 
has been accepted for oral presentation 
at the lOth World Symposiwn on 
Cardiac Pacing and Electrophysiology 
to be held in Buenos Aires, Argentina 
from October 22 to 26. 
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Health Promotion and Disease Prevention News 
Camp HealthRock 
This summer, Lehigh Valley Hospital 
provides the perfect antidote for the 
summertime blues: CamJ? 
HealthRock, a cool, five-day adventure 
exclusively for children. There will be 
plenty for kids to yabba-dabba-do 
including activities that will mix fun 
with learning in the areas of fitness, 
nutrition, and safety, among others. 
Call today to find out how you can 
helJ? your children improve their 
health, take on new challenges and 
responsibilities, and have a lot of fun 
in the process. All educational 
materials, daily lunches and snacks at 
the HealthRock Cafe, along with a 
Camp HealthRock tee-shirt, are 
included in the program fee. 
Registration is limited to 30 children 
per weekly session. 
Remaining sessions will be held from 
July 31 through August 4 (ages 10 to 
12) and August 21 through 25 (ages 7 
to 9). Daily camp sessions are held 
from 8:30 a.m. to 4:30 p.m., with 
drop-off beginning at 7:30a.m., and 
pick-up until5:15 p.m. All sessions 
are located at Lehigh Valley Hospital 
Wellness Center on Fish Hatchery 
Road. 
For more information or to register, 
call Health Promotion and Disease 
Prevention at 402-5960. 
Stand Up to Osteoporosis 
Osteoporosis, which affects over 25 
million Americans, is also known as 
''The Silent Thief," because it 
progresses without any symptoms or 
pain. But through minor lifestyle 
( 
changes including a healthier diet and 
regular, weight-bearing exercise, 
individuals can dramatically reduce 
their chances of developing the disease. 
A two-part program regarding 
Osteoporosis and steps to combat this 
disease will be held on August 9 and 
16, from 1:30 to 3 p.m., at 1243 S. 
Cedar Crest Blvd., Lower Level. For 
more information or to register, call 
402-5960. 
Sm.oking Cessation Hypnosis 
A one-time, hour-long, inexpensive 
program ideal for those q:uitting for 
either the first time or after many 
tries. Led by a certified hypnotherapist 
and psychologist, this program may be 
used in conjunction with other 
smoking cessation programs to 
increase the participant's ability to 
quit. 
Sessions will be held on Tuesday, July 
25, from 7 to 8 p.m., and Friday, 
August 11, from 3 to 4 p.m., both in 
Classroom 3 of Lehigh Valley 
Hospital, Cedar Crest & I-78. 
For fees or additional information, call 
402-5960. 
• • • • • 
These and many other programs for 
nutrition and weight control, stress 
management, fitness, and nicotine 
dependence services are available 
through the Health Promotion and 
Disease Prevention Department. 








The August Medical Staff/ 
Administrative Exchange Session 
will be held on Thursday, August 17, 
beginning at 5:30p.m., in Conference 
Room 1, Side B, of the John and 
Dorothy Morgan Cancer Center. 
It is of paramount importance that as 
many physicians as possible attend 
these sessions to participate in the 
exchange of information about 
important topics in a timely manner. 
Topics to be discussed will be posted 
throughout the hospital prior to the 
session. 
For more information, contact John 
E. Castaldo, MD, Medical Staff 
President, through Physician 
Relations at 402-9853. 
Psychiatry Grand Rounds 
Borderline Personality Disorder 
will be presented" by Suzanne Lego, 
RN, PhD, CS, FAAN, private 
practitioner in Pittsburgh, Pa., and 
Kent, Ohio, on Thursday, August 17, 
beginning at noon in the Auditorium 
at 17th & Chew. 
As lunch will be provided, pre-
registration is requested. For more 
information or to register, contact Lisa 
Frick in the Department of Psychiatry 
at 402-2810. 
Hill Burton Program 
Hill Burton funding is available 
to qualifying indigent patients 
who require hospital-based 
services provided by Lehigh 
Valley Hospital. Services such 
as those provided by Lehigh 
Magnetic Imaging Center, 
Lehigh Valley Diagnostic 
Imaging, Affinity, and others 
which are not hospital-based, 
are NOT included inthe Hill 
Burton Program. Patients who 
require but are unable to pay 
for these services should deal 
directly with these ancillary 
departments. 
If you have questions 
regarding this issue, contact 
Sandra Colon, Director of 




The Who's New section of Medica/ 
Staff Progress Notes contains an 
update of new appointments, address 
changes, newly approved privileges, etc. 
Please remember that each department 
or unit is responsible for updating its 




Eugene Alexandrin, MD 
Lehigh Valley Pathology Associates 
(Dr. Shane) 
Cedar Crest & I-78 
P.O. Box689 
Allentown, PA 18105-1556 
(610) 402-8152 
Department of Pathology 
Division of Clinical and Anatomic 
Pathology 
Provisional Active 
Douglas K. Atno, DMD 
{solo) 
581 Main Street 
P.O. Box 215 
Pennsburg, PA 18073-0215 
(215) 679-9675 
Department of Dentistry 
Division of General Dentistry 
Provisional Active 
Jon E. Brndjar, DO 
Lehigh Valley Physician Group 
Lehigh Valley Hospital 
Cedar Crest & 1-78 
Allentown, PA 18105-1556 
(610) 402-1150 
FAX: (610) 402-1675 
Department of Medicine 
Division of General Internal Medicine 
Provisional Active 
Masayuki Kazahaya, MD 
(Drs. Buchanan and Oliver) 
Fairgrounds Medical Center 
400 N. 17th Street, #200 
Allentown, PA 18104-5052 
(610) 433-2021 
FAX: (610) 433-7856 
Department of Surgery 
Division of Ophthalmology 
Provisional Active 
Steven}. Perch, MD 
Allentown Radiation Oncology 
Associates 
(Dr. Risch) 
John & Dorothy Morgan Cancer 
Center 
Cedar Crest & I-78 
Allentown, PA 18105-1556 
(610) 402-0700 
FAX: (610) 402-0708 
Department of Radiation Oncology 
Provisional Active 
Neal A. Stans.bury, MD 
Valley Sports & Arthritis Surgeons 
(Dr. Sussman) 
1230 S. Cedar Crest Blvd. 
Suite 101 
Allentown, PA 18103-6237 
(610) 820-5200 
FAX: (610) 820-0359 
Department of Surgery 
Division of Orthopedic Surgery 
Provisional Active 
Fa-r L. Stricklin, DMD 
(solo) 
31 S. 17th Street 
Easton, PA 18042-3980 
(610) 252-0646 
Department of Dentistry 
Division of General Dentistry 
Provisional Active 
(Continued on Page 13) 
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Prodrornos A. Ververeli, MD 
Valley Sports & Arlhriti~ Surgeons 
(Dr. Sussman) 
1230 S. Cedar Crest Blvd. 
Suite 101 
Allentown, PA 18103-6237 
(610) 820-5200 
FAX: (610) 820-0359 
Department of Surgery 
Division of Orthopedic Surgery 
Provisional Active 
James C. Weis, MD 
Orthopaedic Associates of Allentown 
(Dr. Keblish) 
1243 S. Cedar Crest Blvd. 
Suite 2500 
Allentown, PA 18103-7982 
(610) 433-6045 
FAX: (610) 433-3605 
Department of Surgery 
Division of Orthopedic Surgery 
Provisional Active 
Additional Privileges 
Kenneth P. Skorinko, MD 
Department of Medicine 
Division of Cardiology 
Direct Coronary Atherectomy 
Privileges 
Address Changes 
Mishkin Rappaport Shore Rentler 
Internal Medicine 
Mark H. Mishkin, MD (Effective 
August 4, 1995) 
Russell J. Rentler, MD (Effective 
August 21, 1995) 
Stephen R. Shore, MD (Effective 
August 4, 1995) 
1251 S. Cedar Crest Blvd. 
Suite 112 
Allenlown, PA 18103-6244 
Brian L. Fellechner, DO 
Good Shepherd Rehab Hospital 
501 St. John Street 
Allentown, PA 18103-3296 
(610) 776-3278 
FAX: (610) 776-3172 
Telephone Number Change 
Yasin N. Khan, MD 
Lehigh Valley Pain Management 
(610) 366-9000 
FAX: (610) 366-9229 
Leave of Absence - Additional 
Year 
Harry W. Stephens, MD 
Department of Surgery 
Division of Neurological Surgery 
Emeritus Active/LOA 
Resignation 
Ralph H. Scott, MD 
Department of Pathology 
Division of Clinical and Anatomic 
Pathology 
Allied Health Professionals 
Additional Privileges 




Change of Supervising 
Physician 
Sandra J. Vitello, PNP 
Physician Extender 
Professional - PNP 
(Hospital) 
Change from Charles F. Smith, MD 




P & T HIGHLIGHTS 
The following actions were taken at the June 21, 1995 Pharmacy 
and Therapeutics Committee Meeting- Maria Barr, Pharm.D., 
Barbara Leri, Pharm.D. 
H2 ANTAGONIST 48 HOUR STOP 
Overuse of H2 antagonists is well 
documented in the literature. The 
conunittee discussed the current use at L VH 
and raised many concerns. The potential 
side effects including CNS and hematologic 
abnormalities appear to out weigh the 
benefits of routine use in hospitalized 
patients. One service has already addressed 
this issue. The trauma service stress ulcer 
prophylaxis protocol reserves H2 antagonist 
therapy for patients at high risk only and 
utilizes sucralfate first line therapy. This 
protocol realized an annualized savings of 
approximately $10,000. 
In an effort to eliminate unnecessary and 
prolonged therapy with H2 antagonists for 
stress ulcer prophylaxis, a 48 hour 
automatic stop has been approved and will 
begin July 24, 1995. Physicians MUST 
reorder H2 antagonist therapy for 
continuation. 
GLUCOPHAGE ... THE 
SUCCESSOR OF PHENFORMIN 
IS HERE AT LVH 
A recently approved agent, Glucophage 
(MetforminR, Bristol-Myers Squibb), has 
been approved for addition to the formulary. 
It is a non-sulfonylurea which may be used 
alone as an adjunct to diet or in combination 
with a sulfonylurea which is not adequately 
controlling blood sugars in NIDDM. 
Glucophage improves glucose tolerance in 
NIDDM patients by lowering both the basal 
and postprandial plasma glucose. 
Glucophage works differently compared to 
the sulfonylureas through a decrease in 
hepatic glucose production, a decrease in 
intestinal absorption of glucose and 
improvement of insulin sensitivity. 
Hypoglycemia does not result from, 
glucophage therapy, adding to the advantage 
of this agent. 
Concerns related to the potential adverse 
effects of glucophage, especially lactic 
acidosis was addressed by endocrine. Lactic 
acidosis, though rare, can occur secondarily 
to accumulation of glucophage. When it 
occurs, it is fatal in 50% of the cases. 
Reported cases have occurred primarily in 
diabetic patients with significant renal 
insufficiency. The risk of lactic acidosis 
increases with the degree of renal 
dysfunction and the patient's age. Due to 
impaired hepatic function, the body may not 
be able to adequately clear lactate. Patients 
should be cautioned against excessive 
alcohol intake while receiving metformin 
due to alcohol's ability to potentiate the 
effect of glucophage on lactate metabolism. 
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Glucophage is considered to be 
contraindicated in patients with renal disease 
or renal dysfunction, suggested by a serum 
creatinine of 2.. 1.5mg/dl. The drug should 
be temporarily withheld (at least 48 hours 
prior to and 48 hours after procedure) in 
patients undergoing radiologic studies 
involving parenteral contrast dyes due to the 
possibility of acute changes in renal 
dysfunction with the use of these agents. 
Finally, the drug should be withheld in 
patients with any type of hypersensitivity to 
metformin or have an underlying chronic 
metabolic acidosis including diabetic 
ketoacidosis with or without coma. 
Many precautions exist for glucophage, 
some of which include the monitoring of 
renal function, concomitant use of other 
medications which alter renal function, 
hypoxic states, alcohol intake and impaired 
hepatic function. 
In addition to lactic acidosis, other potential 
adverse effects include gastrointestinal 
reactions, alteration of taste and 
asymptomatic subnormal vitamin B12 levels. 
The usual starting dose for glucophage is 
500mg PO BID administered with the 
morning and evening meal with dosage 
increments of one tablet every week to a 
maximum of 2550mg/day. The usual 
maintenance dose is 850mg PO BID. 
Monitoring of glycosolated hemoglobin 
should occur approximately every three 
months. Fasting plasma glucose should be 
used to determine the therapeutic response 
to glucophage. 
The expected costs of this agent will range 
from $0.70 to $1.95/day. 
An educational chart memo is in 
development to assist physicians with 
monitoring and managing patients on 
glucophage while hospitalized. 
NO MORE PHONE CALLS .... 
EXPANSION OF THE 
THERAPEUTIC SUBSTITUTION 
LIST 
By popular demand, we have revised the 
therapeutic substitution list at L VH to 
include frequently ordered non-formulary 
medications. Historically, a physician 
would receive a phone call for every non-
formulary medication ordered to change it to 
an available formulary agent. A list was 
developed of the most frequent non-
formulary medications orders to eliminate 
the need for phone calls. A therapeutic 
substitution including dosages for the listed 
agents will automatically occur with an 
order change sent from pharmacy. 
Physicians may continue patients personal 
supply from home, with a written order 
stating "patient may use own supply" next to 
the medication order. The list of agents is 





lisinopril (Zestril, Prinivil) 






acetaminophen 650mg and 
propoxyphene 1 OOmg (Darvocet N 1 00) 
cefuroxime axetil (Ceftin) 
oxycodene 5mg and APAP 325mg 
(Percocet) 
calcium carbonate (Titralac) 
cholestyramine powder (Questran) 
cephlalexin (Keflex) 
isosorbide mononitrate (lsmo) 






enteric coated ASA 81mg 
clarithromycin (Biaxin) 





metoprolol XL (Toprol XL) 
tramadol (Ultram) 
cefaclor (Ceclor) capsules 
- hydrocodone bitartrate 5mg 
and AP AP 500mg (Vicodin) 
- hydrocodone bitartrate 7. 5mg 
and APAP 750mg (Vicodin ES) 
calcium carbonate (Turns) 
colestipol granules (Celestid) 
cefadroxil (Duricet) 
isosorbide mononitrate (lmdur) 
guaifenesin LA (Humibid LA) 
nitrofurantoin SR (Macrobid) 
glipizide XL (Glucotrol XL) 
(QD orders only) 
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A NEW TWIST FOR OLD 
DRUGS ..• AMINOGLYCOSIDES 
EXTENDED- DOSING INTERVAL 
Many institutions have adopted an extended-
interval dosing regimen for 
aminoglycosides. The relatively n~vel 
approach to administering aminoglyc~stdes 
is based on two important properties of 
these drugs. First, aminoglycosides have 
concentration-dependent activity. The 
higher the concentration, the better killing 
activity of the aminoglycosides. Secondly, 
aminoglycosides possess a "post-antibiotic" 
effect. Even though there may be an 
undetectable amount of aminoglycoside in 
the patients system, suppression of the 
bacteria can still be achieved. 
The dosing of either gentamicin or 
tobramycin would be achieved through using 
5mg/kg (based on ideal body weight) 
administered once daily in patients with 
nonnal renal function i.e. estimated CrCI 
> 50mllmin. The dosing interval would be 
extended to Q36 hours for patients with 
estimated CrCI between 30-49 ml/min and 
Q48 hours for 20-29 ml/min, respectively. 
Patients with CrCl < 20ml/min or with 
ARF should receive a single dose of 2mg/kg 
(IBW) and the dose should be adjusted based 
on levels and dialysis schedule, if 
applicable. 
Monitoring of extended-interval 
aminoglycosides is less complex than the 
present recommendations. Renal function 
needs to be assessed a minimum of Q3 days 
while receiving aminoglycosides. Only a 
random level 16-20 hours post-dose needs to 
be assessed. The latter offers the advantage 
of having the random level available prior to 
the next dose. It would allow for extension 
of the dosing interval, if necessary. The 
random level should be < lmg/dl to 
prevent accumulation of the drug. If the 
random level is less than lmg/dl, DO NOT 
shorten the dosing interval. This level is 
meant to monitor for avoidance of toxicity 
rather than interpretation for therapeutic 
effect. The specific time of monitoring a 
random level should be indicated on the 
physicians order. Random levels between 
16-20 hours after the dose can be checked 
following the first dose and Q5-7 days, 
thereafter, if necessary, assuming renal 
function is stable. More frequent 
monitoring may be necessary for rapidly 
changing renal function. Peak levels do not 
need to be monitored utilizing the extended-
interval dosing. The high serum 
concentrations achieved by this dosing 
regimen negate the need to check peak 
concentrations for aminoglycosides. 
Certain patients may not be candidates for 
extended interval. These populations 
include: 
- neutropenic patients (ANC < 1000) 
- suspected or documented treatment of endocarditis 
- patient with cystic fibrosis, cirrhosis, ascites or 
myasthenia gravis 
- pregnant patients or nursing mothers 
- patients on dialysis or ARF patients 
- patients treated for staphylococcal or enterococcal 
infection when aminoglycosides are used for synergy 
- patients with a h/o drug-induced ototoxicity 
Dosing: 
A. Calculate Creatine Clearance 
Males: (140-age) x IBW 
Scr x 72 
Females: CrCI(males) x 0.85 
IBW = ideal body weight (See chart on next page) 










2mg/kg x 1, 
then dose by levels 
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Ideal Body Weight 
Males Females 
Ht Wt Ht Wt 
(in) (kg) (in) (kg) 
60 50 60 46 
61 52 61 48 
62 55 62 50 
63 51 63 52 
64 59 64 55 
65 62 65 51 
66 64 66 59 
61 66 61 62 
68 68 68 64 
69 71 69 66 
10 13 70 69 
71 75 71 71 
72 78 72 13 
13 80 73 15 
14 82 74 18 
15 85 75 80 
16 81 76 82 
11 89 11 85 
78 91 18 81 
19 94 79 89 
80 96 80 92 
For dosing weight, actual body weight may 
be used if patient is not obese. If patient is 
obese ( > 20% ideal body weight), take 40% 
of the excess weight and add to IBW i.e. 
obese patient dosing weight = 0.4 x (actual 
body weight - ideal body weight) + ideal 
body weight. 
In published data regarding extended-dosing 
regimens for aminoglycosides, a greater 
incidence of adverse effects have not been 
demonstrated, specifically looking at oto-
and nephrotoxicity. 





please contact the 
pharmacy. 
P.S. If extended-interval .. dosing of 
aminoglycosides is not appropriate for your 
patient, a nomogram exists to assist you in 
selecting therapeutic. doses. Please refer to 
the following nomogram: 
HULL & SARUBBI NOMOGRAM 
FOR GENTAMICIN and TOBRAMYCIN DOSING 
1. Select loading dose in mg/k9 (LEAN WEIGHT) to provide peak 
serum level desired. Approximate peak levels from commonly 
used loading doses are indicated below: 
lOADING DOSE EXPECTED PEAK SERUM lEVEl lASED UPON ONE·HOUR IV INFUSION 
2.0 mg/kg 6·1 ug/ml 
1 7S mg/kg' S·l ug/ml 
I S mglkg 4·6 ug/ml 
1.2S mg/kg 3·S ug/ml 
1.0 mgikg 2·4 u9/ml 
'IRecommencleG lot mosl moderalllo severe sysltiiiiC onlecloons.l 
2. Select Maintenance Dose (as percentage of chosen loading dose) 
to continue peak serum levels indicated above according to 
patient's creatinine clearance and desired dosing intervals. 
PERCENTAGE OF LOADING DOSE REQUIRED 












12 hrs. 24 hrs. 
'l ~~ 
CrCI (males) = (140-Age) x (Weight) 
SCr x 72 
or 
CrCI (males) = (140-Age) 
Scr 
CrCI (female) = 0.85 x either of above values 
CrCI = creatinine clearance in mllmin 
Scr = serum creatinine in mg/dl 
Age is in years • Weight is in kg. 
Hull & Sarubbi. AnNis at lntlfftil Mtdic1ne 85.183·189. 1976 
PLEASE NOTE: For patients who have an 
estimated CrCl < 50ml/min or whose age 
2.. 70 years, a Q12 hours rather than Q8 
hour dosing interval should be selected to 
allow for the drug to be adequately cleared 
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